* Receives authorization to sell assets to Angiotech Pharma
* Gets second extension to April 19 on proposal to
March 22 Haemacure Corp HAEFQ.PK said it
received permission from the Superior Court of the Province of
Quebec to sell its assets to Angiotech Pharmaceuticals Inc
ANP.TO, a secured creditor of Haemacure.
The Canada-based biotherapeutic company said the United
States Bankruptcy Court had previously authorized the sale to
Angiotech of the assets of Haemacure's U.S. subsidiary.
Haemacure also said it obtained a second extension, until
April 19, within which to make a proposal to its creditors.
The extension will also allow Haemacure and Angiotech to
complete the documentation required for the closing of the
asset-sale transactions in Canada and the United States. The
closings are expected to be held prior to the new expiry date
of April 19.
(Reporting by Isheeta Sanghi in Bangalore; Editing by Mike
Miller) ((email@example.com; within U.S. +1 646
223 8780; outside U.S. +91 80 4135 5800; Reuters Messaging: